Published in Am J Epidemiol on February 15, 2004
Social determinants: taking the social context of asthma seriously. Pediatrics (2009) 2.19
Association of dietary soy genistein intake with lung function and asthma control: a post-hoc analysis of patients enrolled in a prospective multicentre clinical trial. Prim Care Respir J (2012) 1.41
Use of NHANES data to link chemical exposures to chronic diseases: a cautionary tale. PLoS One (2012) 1.04
Effects of all-trans retinoic acid on Th1- and Th2-related chemokines production in monocytes. Inflammation (2008) 0.97
Diet and allergic diseases among population aged 0 to 18 years: myth or reality? Nutrients (2013) 0.89
Obesity, Nutrition, and Asthma in Children. Pediatr Allergy Immunol Pulmonol (2012) 0.89
Association of antioxidants with allergic rhinitis in children from seoul. Allergy Asthma Immunol Res (2012) 0.84
Nutritional supplements and plasma antioxidants in childhood asthma. Wien Klin Wochenschr (2013) 0.81
Impact of Adjunctive Therapy with Chlorellav ulgaris Extract on Antioxidant Status, Pulmonary Function, and Clinical Symptoms of Patients with Obstructive Pulmonary Diseases. Sci Pharm (2012) 0.81
Dietary supplements and asthma: another one bites the dust. Thorax (2007) 0.80
Mega-dose vitamin C attenuated lung inflammation in mouse asthma model. Anat Cell Biol (2010) 0.77
Effect of Retinoic Acid in a Mouse Model of Allergic Rhinitis. Allergy Asthma Immunol Res (2015) 0.77
Evaluation of oxidative stress via total antioxidant status, sialic acid, malondialdehyde and RT-PCR findings in sheep affected with bluetongue. Vet Rec Open (2015) 0.77
Carotenoid intake and asthma prevalence in Thai children. Pediatr Rep (2012) 0.76
Adult-onset asthma prevention. Should we be investing in antioxidant defense? Am J Respir Crit Care Med (2015) 0.75
Oxidative Stress and Bronchial Asthma in Children-Causes or Consequences? Front Pediatr (2017) 0.75
The pathophysiological role of mitochondrial oxidative stress in lung diseases. J Transl Med (2017) 0.75
The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med (2005) 8.86
Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med (2009) 5.90
Randomized comparison of strategies for reducing treatment in mild persistent asthma. N Engl J Med (2007) 4.40
Lansoprazole for children with poorly controlled asthma: a randomized controlled trial. JAMA (2012) 3.40
The minimal important difference in the 6-minute walk test for patients with pulmonary arterial hypertension. Am J Respir Crit Care Med (2012) 3.24
The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging. Diabetes (2003) 3.23
Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy. J Clin Oncol (2006) 3.09
Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J Am Coll Cardiol (2004) 2.91
Club cell protein 16 and disease progression in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2013) 2.82
Pulse wave velocity is an independent predictor of the longitudinal increase in systolic blood pressure and of incident hypertension in the Baltimore Longitudinal Study of Aging. J Am Coll Cardiol (2008) 2.75
Maternal vitamin A supplementation and lung function in offspring. N Engl J Med (2010) 2.61
Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy. Cancer (2006) 2.10
Spirometric predictors of lung function decline and mortality in early chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2012) 2.09
Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax (2007) 2.05
Six-minute walk distance in chronic obstructive pulmonary disease: reproducibility and effect of walking course layout and length. Am J Respir Crit Care Med (2003) 2.03
The effect of HIV infection on longitudinal lung function decline among IDUs: a prospective cohort. AIDS (2013) 1.92
Body mass index and the risk of COPD. Chest (2002) 1.91
Paradoxical physical findings described by Kussmaul: pulsus paradoxus and Kussmaul's sign. Lancet (2002) 1.85
Natural history of mild-moderate pulmonary hypertension and the risk factors for severe pulmonary hypertension in scleroderma. J Rheumatol (2006) 1.73
The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality: data from the Baltimore Longitudinal Study of Aging with a critical review of the literature. Diabetes Care (2005) 1.70
Aging, androgens, and the metabolic syndrome in a longitudinal study of aging. J Clin Endocrinol Metab (2007) 1.70
Asthma in the elderly: Current understanding and future research needs--a report of a National Institute on Aging (NIA) workshop. J Allergy Clin Immunol (2011) 1.69
Physician and patient perceptions in COPD: the COPD Resource Network Needs Assessment Survey. Am J Med (2005) 1.67
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2015) 1.63
Methacholine challenge test: diagnostic characteristics in asthmatic patients receiving controller medications. J Allergy Clin Immunol (2012) 1.57
The IBV Valve trial: a multicenter, randomized, double-blind trial of endobronchial therapy for severe emphysema. J Bronchology Interv Pulmonol (2014) 1.51
Activation-induced cell death drives profound lung CD4(+) T-cell depletion in HIV-associated chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2014) 1.50
The complex relationship of serum adiponectin to COPD outcomes COPD and adiponectin. Chest (2012) 1.50
Feasibility of retinoids for the treatment of emphysema study. Chest (2006) 1.45
Lung Density Changes With Growth and Inflation. Chest (2015) 1.42
Association of dietary soy genistein intake with lung function and asthma control: a post-hoc analysis of patients enrolled in a prospective multicentre clinical trial. Prim Care Respir J (2012) 1.41
Changes in smoking status affect women more than men: results of the Lung Health Study. Am J Epidemiol (2003) 1.33
Sex differences in mortality and clinical expressions of patients with chronic obstructive pulmonary disease. The TORCH experience. Am J Respir Crit Care Med (2010) 1.33
Clinical research in chronic obstructive pulmonary disease: needs and opportunities. Am J Respir Crit Care Med (2003) 1.32
Scleroderma patients with combined pulmonary hypertension and interstitial lung disease. J Rheumatol (2003) 1.31
Effect of obesity on clinical presentation and response to treatment in asthma. J Asthma (2006) 1.26
Serum PARC/CCL-18 concentrations and health outcomes in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2011) 1.23
Racial difference in lung function in African-American and White children: effect of anthropometric, socioeconomic, nutritional, and environmental factors. Am J Epidemiol (2004) 1.23
Ubiquitination is involved in glucose-mediated downregulation of GIP receptors in islets. Am J Physiol Endocrinol Metab (2007) 1.22
Effect of urbanisation on asthma, allergy and airways inflammation in a developing country setting. Thorax (2011) 1.20
Allergic rhinitis and sinusitis in asthma: differential effects on symptoms and pulmonary function. Chest (2006) 1.17
Association between obstructive lung disease and markers of HIV infection in a high-risk cohort. Thorax (2011) 1.16
Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis. Ann Rheum Dis (2007) 1.15
Prediction of acute respiratory disease in current and former smokers with and without COPD. Chest (2014) 1.15
Mortality in COPD: causes, risk factors, and prevention. COPD (2010) 1.14
Variability of spirometry in chronic obstructive pulmonary disease: results from two clinical trials. Am J Respir Crit Care Med (2006) 1.14
Telomerase mutations in smokers with severe emphysema. J Clin Invest (2014) 1.11
Treadmill endurance during 2-year treatment with tiotropium in patients with COPD: a randomized trial. Chest (2013) 1.09
Sleep quality in asthma: results of a large prospective clinical trial. J Asthma (2008) 1.08
Anxiety is associated with diminished exercise performance and quality of life in severe emphysema: a cross-sectional study. Respir Res (2010) 1.07
Cross sectional analysis of respiratory symptoms in an injection drug user cohort: the impact of obstructive lung disease and HIV. BMC Pulm Med (2010) 1.06
Oxygen therapy in chronic obstructive pulmonary disease. Proc Am Thorac Soc (2008) 1.04
Age and risk of pulmonary arterial hypertension in scleroderma. Chest (2003) 1.02
Effects of asymptomatic proximal and distal gastroesophageal reflux on asthma severity. Am J Respir Crit Care Med (2009) 1.01
Chronic exposure to biomass fuel is associated with increased carotid artery intima-media thickness and a higher prevalence of atherosclerotic plaque. Heart (2013) 1.01
Adherence to inhaled corticosteroids: an ancillary study of the Childhood Asthma Management Program clinical trial. J Allergy Clin Immunol (2011) 1.01
Eosinophil and T cell markers predict functional decline in COPD patients. Respir Res (2009) 1.00
Effects of distance from a heavily transited avenue on asthma and atopy in a periurban shantytown in Lima, Peru. J Allergy Clin Immunol (2011) 1.00
Increased matrix metalloproteinase (MMPs) levels do not predict disease severity or progression in emphysema. PLoS One (2013) 1.00
Transforming growth factor-beta receptor-3 is associated with pulmonary emphysema. Am J Respir Cell Mol Biol (2009) 0.98
Criteria to screen for chronic sinonasal disease. Chest (2009) 0.98
Association of prostate cancer risk with insulin, glucose, and anthropometry in the Baltimore longitudinal study of aging. Urology (2004) 0.98
Asthma symptom utility index: reliability, validity, responsiveness, and the minimal important difference in adult asthmatic patients. J Allergy Clin Immunol (2012) 0.96
Exercise testing in severe emphysema: association with quality of life and lung function. COPD (2008) 0.96
Racial differences in CT phenotypes in COPD. COPD (2013) 0.95
Chronic obstructive pulmonary disease: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases. Ann Am Thorac Soc (2014) 0.95
Prevalence and risk factors for unrecognized obstructive lung disease among urban drug users. Int J Chron Obstruct Pulmon Dis (2011) 0.95
Field tests of exercise in COPD: the six-minute walk test and the shuttle walk test. COPD (2007) 0.94
Glucose tolerance, glucose utilization and insulin secretion in ageing. Novartis Found Symp (2002) 0.94
Elevated plasma glucose-dependent insulinotropic polypeptide associates with hyperinsulinemia in impaired glucose tolerance. Diabetes Care (2004) 0.93
Adult asthma severity in individuals with a history of childhood asthma. J Allergy Clin Immunol (2005) 0.93
Does age impact the obese asthma phenotype? Longitudinal asthma control, airway function, and airflow perception among mild persistent asthmatics. Chest (2011) 0.93
Aquaporin 5 polymorphisms and rate of lung function decline in chronic obstructive pulmonary disease. PLoS One (2010) 0.92
Chronic intermittent hypoxia induces lung growth in adult mice. Am J Physiol Lung Cell Mol Physiol (2010) 0.90
Effects of high-dose isoflavones on metabolic and inflammatory markers in healthy postmenopausal women. Menopause (2009) 0.90
Loss of bone density with inhaled triamcinolone in Lung Health Study II. Am J Respir Crit Care Med (2004) 0.89
Genome-wide study identifies two loci associated with lung function decline in mild to moderate COPD. Hum Genet (2012) 0.88
Accuracy of death certificates in COPD: analysis from the TORCH trial. COPD (2010) 0.88
Association of CYP2C19 polymorphisms and lansoprazole-associated respiratory adverse effects in children. J Pediatr (2013) 0.87
Contribution of impaired glucose tolerance in subjects with the metabolic syndrome: Baltimore Longitudinal Study of Aging. Metabolism (2005) 0.87
Circulating surfactant protein-D and the risk of cardiovascular morbidity and mortality. Eur Heart J (2011) 0.87
Relationship between lung function impairment and health-related quality of life in COPD and interstitial lung disease. Chest (2012) 0.86
Optimizing the 6-min walk test as a measure of exercise capacity in COPD. Chest (2012) 0.86
HIV and COPD: impact of risk behaviors and diseases on quality of life. Qual Life Res (2010) 0.86
Relation between duration of androgen deprivation therapy and degree of insulin resistance in men with prostate cancer. Arch Intern Med (2007) 0.86
Chronic productive cough is associated with death in smokers with early COPD. COPD (2013) 0.86
The Madison Avenue effect: how drug presentation style influences adherence and outcome in patients with asthma. J Allergy Clin Immunol (2011) 0.85
Measurement variability in single-breath diffusing capacity of the lung. Chest (2003) 0.85
Changes in arterial oxygenation and self-reported oxygen use after lung volume reduction surgery. Am J Respir Crit Care Med (2008) 0.84
The degree of skin involvement identifies distinct lung disease outcomes and survival in systemic sclerosis. Ann Rheum Dis (2013) 0.84
Is longitudinal pulse pressure a better predictor of 24-hour urinary albumin excretion than other indices of blood pressure? Hypertension (2009) 0.84
Effect of cigarette smoke exposure and structural modifications on the α-1 Antitrypsin interaction with caspases. Mol Med (2012) 0.83
Measures of asthma control. Curr Opin Pulm Med (2012) 0.83
HIV Infection Is Associated With Increased Risk for Acute Exacerbation of COPD. J Acquir Immune Defic Syndr (2015) 0.82
The relation of serum myeloperoxidase to disease progression and mortality in patients with chronic obstructive pulmonary disease (COPD). PLoS One (2013) 0.81
Elevated HDL cholesterol levels are associated with osteoporosis in lung transplant candidates with chronic obstructive pulmonary disease. Respir Med (2010) 0.81